217 related articles for article (PubMed ID: 16385401)
1. Effect of pravastatin on plasma sterols and oxysterols in men.
Thelen KM; Lütjohann D; Vesalainen R; Janatuinen T; Knuuti J; von Bergmann K; Lehtimäki T; Laaksonen R
Eur J Clin Pharmacol; 2006 Jan; 62(1):9-14. PubMed ID: 16385401
[TBL] [Abstract][Full Text] [Related]
2. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
3. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.
Lütjohann D; Stroick M; Bertsch T; Kühl S; Lindenthal B; Thelen K; Andersson U; Björkhem I; Bergmann Kv Kv; Fassbender K
Steroids; 2004 Jun; 69(6):431-8. PubMed ID: 15219793
[TBL] [Abstract][Full Text] [Related]
4. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
5. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels.
Thelen KM; Laaksonen R; Päivä H; Lehtimäki T; Lütjohann D
J Clin Pharmacol; 2006 Jul; 46(7):812-6. PubMed ID: 16809807
[TBL] [Abstract][Full Text] [Related]
6. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
[TBL] [Abstract][Full Text] [Related]
7. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
8. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.
Locatelli S; Lütjohann D; Schmidt HH; Otto C; Beisiegel U; von Bergmann K
Arch Neurol; 2002 Feb; 59(2):213-6. PubMed ID: 11843691
[TBL] [Abstract][Full Text] [Related]
9. The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans.
Kallien G; Lange K; Stange EF; Scheibner J
Hepatology; 1999 Jul; 30(1):14-20. PubMed ID: 10385633
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol.
Lütjohann D; Björkhem I; Locatelli S; Dame C; Schmolling J; von Bergmann K; Fahnenstich H
Acta Paediatr; 2001 Jun; 90(6):652-7. PubMed ID: 11440099
[TBL] [Abstract][Full Text] [Related]
11. The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies.
Stellaard F; von Bergmann K; Sudhop T; Lütjohann D
J Steroid Biochem Mol Biol; 2017 May; 169():111-122. PubMed ID: 27060336
[TBL] [Abstract][Full Text] [Related]
12. Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
Berthold HK; Sudhop T; von Bergmann K; Gouni-Berthold I
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):364-72. PubMed ID: 20693157
[TBL] [Abstract][Full Text] [Related]
13. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
14. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
[TBL] [Abstract][Full Text] [Related]
15. Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry.
Burkard I; Rentsch KM; von Eckardstein A
J Lipid Res; 2004 Apr; 45(4):776-81. PubMed ID: 14729854
[TBL] [Abstract][Full Text] [Related]
16. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
Zuliani G; Donnorso MP; Bosi C; Passaro A; Dalla Nora E; Zurlo A; Bonetti F; Mozzi AF; Cortese C
BMC Neurol; 2011 Oct; 11():121. PubMed ID: 21970714
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
[TBL] [Abstract][Full Text] [Related]
18. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Harsch M; Gebhardt A; Reymann A; Lang G; Schliack M; Löser R; Braesen JH; Niendorf A
Br J Pharmacol; 1998 May; 124(2):277-82. PubMed ID: 9641543
[TBL] [Abstract][Full Text] [Related]
19. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
Vega GL; Weiner MF
J Mol Neurosci; 2007 Sep; 33(1):51-5. PubMed ID: 17901546
[TBL] [Abstract][Full Text] [Related]
20. Degradation of 24S-hydroxycholesterol in men is not regulated by CYP7A1.
Knabe C; Sudhop T; von Bergmann K; Lütjohann D
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):577-82. PubMed ID: 18077921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
